Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Moodys
Medtronic
McKesson
Mallinckrodt

Get more done, faster

Accurate, objective, and timely intelligence to help you make better decisions


4.3/5 based on G2 reviews

4.4/5 based on Crozdesk reviews

Flexible Pricing Adapts to Your Needs


 

Free

Limited free access

$0

 
  • Limited searches each month
  • Some restrictions on platform functions
 

Limited

For low-volume use

Starting at $250

/ month
  • 35 searches per month
  • Includes all Modules
  • Daily Briefing Email Bulletin
  • Certificate Course on Branded Lifecycle Management and Generic Entry
  • Copy of Make Better Decisions book
MOST POPULAR 

Unlimited

Simple flat-rate access

$2,100

/ month

$19,250

/ year

    All Limited Plan Features, plus:

  • Data export to Excel or .csv file
  • Unlimited Searches
 

Enterprise

For teams

    All Unlimited Plan features, plus:

    • Multiple Users, or Company-Wide Access

Each plan includes the following modules


Pharmaceutical Drugs

  • US & International Patents
  • Active and Expired Patents in 134 Countries, Regulatory Protections and Exclusivities
  • Anticipate Generic Entry
  • Loss-of-Exclusivity Dates, Paragraph IV Challenges, Tentative Approvals, Authorized Generics, and more…
  • Find Commercial Opportunities
  • Single Source Off-Patent Drugs, Search Patents by Dosage Form / Therapeutic Class
  • Drug Sourcing
  • API, Finished Product Suppliers, First Generic Entrants

Biologic Drugs

  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Track Biosimilar Development
  • Finished Product Suppliers
  • Manufacturers

Excipients

  • Tie inactive ingredients to drug patents
  • Track drug patents based on their excipients
  • Identify clients for excipients
  • Find upcoming generic manufacturers needing your inactive ingredients

Investigational Drugs

  • Drug Candidates in Phase I-III Clinical Trials
  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Clinical Trial Progress
  • API Vendors

US Drug Patent Litigation

  • US District Court Cases
  • Patent Infringement, Contract Disputes, Antitrust, etc.
  • Patent Trial and Appeal Board
  • PTAB inter partes review, post-grant review

US Drug Prices

  • Brand vs. Generic Drug Price Gap
  • Find generic entry opportunities
  • Average Pharmacy Cost
  • Set reasonable launch prices
  • Best-Available Price
  • See price ranges

US Top Drug Sales

  • Annual Gross Revenues & Units Sold
  • Prescription Payment Methods
  • Self-Paid, Private Insurance, Medicaid, etc.
  • Pharmacy Locations & Types
  • Mail-order, Drugstore, in-Clinic, etc.

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

What our Clients Say

❝ I've been using DPW for years and I'm grateful for the responsiveness of the owner, Yali Friedman ❞

❝ I like best … the flexible subscription plans (by module, by month, by year, etc.) ❞

❝ My overall experience with DPW is very positive. The team is generally supportive and their features are growing over time. ❞

❝ Quick and easy to understand summaries, along with all the necessary links for further analysis. ❞

❝ Knowing when drugs are coming off patent and who to contract with has enabled us to stay ahead fo the curve and align ourselves with the proper vendors. ❞

❝ This is a great service with lots of insightful information. ❞

❝ I like the interface, and how it updates with news ❞

❝ Drugpatentwatch is an excellent opportunity for LATAM companies to access information on expired and protected patents from the USA and worldwide in a friendly and easy manner. ❞

Clients in 74 Countries